Gut Inflammation and Biological Age: How Your Microbiome Drives Inflammaging

The gut is home to trillions of bacteria, also known as the gut microbiome, that shape digestion, immunity, and gut inflammation. Roughly 70% of the immune system is thought to sit within this ecosystem, which is precisely why gut inflammation rarely stays local. When the balance of gut bacteria breaks down (dysbiosis) and the gut lining weakens, the resulting inflammatory signals don't just cause digestive discomfort. They feed into chronic, low-grade inflammation that research increasingly links to how fast the body ages at a cellular level.

Want to understand this mechanism in full? Read our guide, Chronic Inflammation & Inflammaging: The Hidden Driver of How You Age.

Inflammaging: when gut inflammation becomes a longevity problem 

Scientists use the term "inflammaging" to describe the chronic, low-grade inflammation that builds up in the body over decades, independent of infection or injury. Unlike the short, protective inflammatory response the immune system mounts against a genuine threat, inflammaging is persistent and largely silent. It's thought to contribute to cellular senescence, which is the process by which cells stop dividing and start releasing their own inflammatory signals, compounding the problem. 

The gut is one of the largest contributors to this lifelong inflammatory load, because it sits at the intersection of the immune system, the microbiome, and the barrier separating the two from the bloodstream. This reframes gut inflammation from a purely digestive issue into a longevity variable: something that can be tracked and managed over time, not just treated when symptoms flare. 

Microbial diversity as a longevity asset 

Rather than thinking in terms of strictly "good" and "bad" bacteria, it's more useful to think about microbial diversity. A gut microbiome with a wide range of bacterial species is generally more resilient. It is better able to compete with pathobionts, maintain the mucus layer, and produce the metabolites the body needs to keep inflammation in check. Diversity tends to decline with age and with poor diet, stress, and antibiotic overuse, and lower diversity is consistently associated with higher levels of systemic inflammatory markers. Protecting and rebuilding that diversity is one of the more actionable longevity levers available. 

The gut-barrier-age axis 

The gut lining is a single layer of cells, held together by tight junctions, that separates the microbiome from the bloodstream. When this barrier is compromised, commonly referred to as "leaky gut", bacterial components and inflammatory molecules that should stay in the gut instead cross into systemic circulation.

One of the most studied culprits is lipopolysaccharide (LPS), a component of certain bacterial cell walls that, once in the bloodstream, triggers a strong immune response. Chronically elevated LPS is associated with the kind of persistent, low-grade inflammation that characterizes inflammaging. By contrast, short-chain fatty acids like butyrate, produced when gut bacteria ferment dietary fibre, help maintain the gut barrier, feed the cells lining the colon, and are associated with a more favourable inflammatory profile. 

Emerging research suggests that this balance between barrier-protective metabolites like butyrate and barrier-disrupting molecules like LPS may influence the systemic inflammatory burden that glycan-based biological age markers are designed to capture, though the exact mechanistic pathway between specific gut metabolites and glycosylation patterns is still being established, and we'd want this confirmed further before treating it as settled science. 

Supporting the gut-barrier-age axis 

The same daily habits that support gut comfort also support this longevity axis — the target is just broader than digestion. A Mediterranean-style diet rich in polyphenols, found in colourful fruit, vegetables, olive oil, and tea, feeds the bacteria that produce butyrate and other protective metabolites, while minimising refined carbohydrates, fried and processed foods, and added sugar reduces the substrate for LPS-producing bacteria.

"These differences in our responses to food and inflammation are mainly driven by non-genetic factors, and that includes our gut microbiome. Both our food responses and our microbiome are mainly under non-genetic control, which means we can modify them. You can change your gut microbes and choose foods that suit your body — and that means you can regain a lot of control."

— Prof. Gordan Lauc, Co-Founder and Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb 

Chronic stress activates proinflammatory pathways in the gut and impairs the vagus nerve connection between brain and gut, so stress-reduction practices, such as meditation, breathing work, time outdoors, adequate downtime, double as barrier-support tools, not just relaxation. Sleep matters for the same reason: poor-quality sleep reduces bacterial diversity and butyrate production, while seven to nine hours supports both.

Prebiotic fibres (flaxseed, legumes, onions, garlic, oats) and probiotic-rich foods (yoghurt, kefir, kimchi, sauerkraut) feed and replenish the bacteria responsible for producing protective metabolites. Regular movement, at least 150 minutes of moderate activity weekly, has similarly been shown to increase butyrate-producing bacterial strains. Targeted supplementation (fish oil, curcumin, L-glutamine, magnesium) can help fill gaps, though it's worth checking with a doctor first, since not everything on the market is well absorbed or well regulated. 

Reducing exposure to environmental toxins, such as triclosan, pesticide residue, BPA, heavy metals, and staying adequately hydrated both support the same underlying barrier function, since the body's ability to clear toxins and maintain the mucus layer depends on it. Occasional dietary resets (whole-food eating, adequate fibre, and for some people intermittent fasting) can support this process, though "detox" supplements should be treated as complementary at best, not a substitute for the daily habits above. 

Measuring whether it's working: GlycanAge 

Diet and lifestyle changes are hard to evaluate from symptoms alone. Gut comfort can improve while systemic inflammation remains elevated, or vice versa. This is where GlycanAge fits in: the test measures chronic inflammation via IgG glycosylation, giving you a way to track your inflammatory and immune-aging status over time, rather than relying on how your gut feels as a proxy for how your body is aging. 

"We see the biological age for our customers, and we see the actions they've taken. We're linking the effect of those actions to the change in biological age, and concluding whether the scientific literature is being borne out in our data — and adjusting our recommendations accordingly."

— Dr. Peter Joshi, Chief Scientific Officer, Humanity Health; Centre for Global Health Research, Usher Institute, University of Edinburgh

The home testing kit uses a simple finger-prick sample sent back to the lab, with results ready in 3–5 weeks and a complimentary 1-1 consultation to help you interpret them and plan next steps. Because biological age responds to sustained changes rather than one-off fixes, retesting is generally most meaningful after several months of consistent habit changes rather than weeks. Several packages are available depending on your goals and budget.

Start your wellness journey today by ordering your GlycanAge home testing kit. 

Frequently asked questions (FAQ)

Is gut inflammation the same as inflammaging? 

Not exactly. Gut inflammation is a localized process; inflammaging is the cumulative, whole-body inflammatory burden that builds over years, to which gut-driven inflammation is one of several contributors. Signs like bloating, fatigue, skin issues, or irregular digestion can suggest gut inflammation, but they don't reliably indicate whether that inflammation has become systemic. Testing for inflammation elsewhere in the body can complete that picture. 

How long does it take to see a change? 

Repairing the gut lining and rebuilding microbial diversity can take anywhere from a few weeks to a few years depending on the extent of the dysbiosis and how consistently the underlying habits are applied. Because biological age markers respond to sustained lifestyle change, tracking progress over months rather than weeks tends to be more meaningful than symptom relief alone. 

How can I test my gut health?

A faecal microbiome test (via your doctor) can assess bacterial composition, and blood or faecal zonulin testing can flag whether the gut lining itself is compromised. Neither test captures the downstream, systemic inflammatory picture on its own. 

External sources

• https://pmc.ncbi.nlm.nih.gov/articles/PMC2515351/ — Vighi G, Marcucci F, Sensi L, Di Cara G, Frati F. Allergy and the gastrointestinal system. Clin Exp Immunol. 2008 Sep;153(Suppl 1):3-6.

• https://pubmed.ncbi.nlm.nih.gov/30046148/ — Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018 Oct;14(10):576-590.

• https://pmc.ncbi.nlm.nih.gov/articles/PMC7762384/ — Badal VD, Vaccariello ED, Murray ER, Yu KE, Knight R, Jeste DV, Nguyen TT. The Gut Microbiome, Aging, and Longevity: A Systematic Review. Nutrients. 2020 Dec 7;12(12):3759. 

• https://pmc.ncbi.nlm.nih.gov/articles/PMC6102557/ — Matt SM, Allen JM, Lawson MA, Mailing LJ, Woods JA, Johnson RW. Butyrate and Dietary Soluble Fiber Improve Neuroinflammation Associated With Aging in Mice. Front Immunol. 2018 Aug 14;9:1832. 

• https://pubmed.ncbi.nlm.nih.gov/36039924/ — Itsiopoulos C, Mayr HL, Thomas CJ. The anti-inflammatory effects of a Mediterranean diet: a review. Curr Opin Clin Nutr Metab Care. 2022 Nov 1;25(6):415-422. 

• https://pmc.ncbi.nlm.nih.gov/articles/PMC5808284/ — Bonaz B, Bazin T, Pellissier S. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front Neurosci. 2018 Feb 7;12:49. 

• https://pmc.ncbi.nlm.nih.gov/articles/PMC7142151/ — González-Moret R, Cebolla A, Cortés X, Baños RM, Navarrete J, de la Rubia JE, et al. The effect of a mindfulness-based therapy on different biomarkers among patients with inflammatory bowel disease: a randomised controlled trial. Sci Rep. 2020 Apr 8;10(1):6071. 

• https://pmc.ncbi.nlm.nih.gov/articles/PMC6769995/ — Dale HF, Rasmussen SH, Asiller ÖÖ, Lied GA. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients. 2019 Sep 2;11(9):2048.